Strides Pharma
STAR.NS
#6030
Rank
โ‚น63.40 B
Marketcap
โ‚น688.00
Share price
-1.61%
Change (1 day)
5.65%
Change (1 year)

Revenue for Strides Pharma (STAR.NS)

Revenue in 2024 (TTM): โ‚น42.50 Billion

According to Strides Pharma's latest financial reports the company's current revenue (TTM ) is โ‚น43.38 Billion. In 2023 the company made a revenue of โ‚น38.72 Billion an increase over the revenue in the year 2022 that were of โ‚น35.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Strides Pharma from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น42.50 B9.75%
2023 โ‚น38.72 B10.03%
2022 โ‚น35.19 B15.48%
2021 โ‚น30.48 B4%
2020 โ‚น29.30 B1.53%
2019 โ‚น28.86 B29.65%
2018 โ‚น22.26 B-21.95%
2017 โ‚น28.52 B-13.97%
2016 โ‚น33.15 B37.82%
2015 โ‚น24.05 B